ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,859.85
      0.77%
      US Tech 100
      19,852.80
      -0.24%
      Dow Jones
      43,065.22
      0.47%
      Brent Oil
      73.875
      -1.38%
      Bitcoin
      65,698.99
      -0.54%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Immunocore Holdings PLC (IMCR) Quote

      Immunocore Holdings PLC

      Immunocore Holdings PLC (IMCR)

      NASDAQ
      32.19
      1.10
      (3.54%)
      Closed October 14 4:00PM
      Delayed by 15 minutes
      32.19
      0.00
      ( 0.00% )
      Pre Market: 4:00AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      32.19
      Bid
      28.07
      Ask
      34.00
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      1.548B
      Previous Close
      32.19
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      48,088,346
      Dividend Yield
      -
      PE Ratio
      -28.00
      Earnings Per Share (EPS)
      -1.15
      Revenue
      249.43M
      Net Profit
      -55.29M

      About Immunocore Holdings PLC

      Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority o... Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States. Show more

      Sector
      Noncomml Resh Organizations
      Industry
      Noncomml Resh Organizations
      Website
      www.immunocore.com
      Headquarters
      Oxfordshire, Gbr
      Founded
      -
      Immunocore Holdings PLC is listed in the Noncomml Resh Organizations sector of the NASDAQ with ticker IMCR. The last closing price for Immunocore was $32.19. Over the last year, Immunocore shares have traded in a share price range of $ 0.00 to $ 0.00.

      Immunocore currently has 48,088,346 shares outstanding. The market capitalization of Immunocore is $1.55 billion. Immunocore has a price to earnings ratio (PE ratio) of -28.00.

      Ask ADVFN Intelligence (AI)

      IMCR Latest News

      More News

      Form 8-K - Current report

      September 16 2024
      Edgar (US Regulatory)

      Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancer

      Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancer Brenetafusp is clinically active as monotherapy and in combination with...

      September 14 2024
      GlobeNewswire Inc.

      Immunocore to present at the 2024 Cantor Global Healthcare Conference

      Immunocore to present at the 2024 Cantor Global Healthcare Conference (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 12 September 2024) Immunocore Holdings plc (Nasdaq:...

      September 12 2024
      GlobeNewswire Inc.

      Form SC 13G - Statement of Beneficial Ownership by Certain Investors

      September 10 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 29 2024
      Edgar (US Regulatory)

      Immunocore announces transition of Chief Financial Officer

      Immunocore announces transition of Chief Financial Officer (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 29 August 2024) Immunocore Holdings plc (Nasdaq: IMCR...

      August 29 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      August 08 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 08 2024
      Edgar (US Regulatory)

      Immunocore reports second quarter financial results and provides a business update

      KIMMTRAK® (tebentafusp-tebn) net revenues of $75.3 million in 2Q 2024 driven by US growth Registrational Phase 3 TEBE-AM trial with KIMMTRAK in previously treated cutaneous melanoma ongoing...

      August 08 2024
      GlobeNewswire Inc.

      Immunocore to report second quarter 2024 financial results and host call on August 8, 2024

      Immunocore to report second quarter 2024 financial results and host call on August 8, 2024 (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 01 August 2024) Immunocore...

      August 01 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DR
      40000000DR
      120000000DR
      260000000DR
      520000000DR
      1560000000DR
      2600000000DR

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      DBGIDigital Brands Group Inc
      $ 0.3601
      (125.34%)
      		4.72M
      LGHLWLion Group Holding Ltd
      $ 0.013
      (60.49%)
      		89
      GRTSGritstone bio Inc
      $ 0.0721
      (33.52%)
      		21.28M
      ZPTAZapata Computing Holdings Inc
      $ 0.1026
      (33.25%)
      		7.96M
      DRUGBright Minds Biosciences Inc
      $ 2.98
      (19.68%)
      		947.76k
      QRTEBQurate Retail Inc
      $ 2.14
      (-44.13%)
      		155
      STIMNeuronetics Inc
      $ 0.713
      (-19.89%)
      		1
      DSYBig Tree Cloud Holdings Limited
      $ 4.25
      (-16.17%)
      		6.11k
      VRPXVirpax Pharmaceuticals Inc
      $ 0.4015
      (-15.65%)
      		6.86k
      LSBLakeShore Biopharma Company Ltd
      $ 3.24
      (-14.51%)
      		1
      GRTSGritstone bio Inc
      $ 0.0721
      (33.52%)
      		21.28M
      ZPTAZapata Computing Holdings Inc
      $ 0.1026
      (33.25%)
      		7.96M
      DBGIDigital Brands Group Inc
      $ 0.3601
      (125.34%)
      		4.72M
      DJTTrump Media and Technology Group Corporation
      $ 33.58
      (12.12%)
      		1.29M
      RANIRani Therapeutics Holdings Inc
      $ 3.70
      (16.35%)
      		1.12M

      IMCR Discussion

      View Posts
      Monksdream Monksdream 4 weeks ago
      IMCR not looking so hot
      👍️0
      Monksdream Monksdream 6 months ago
      IMCR over $30
      👍️0

      Your Recent History

      NASDAQ
      IMCR
      Immunocore
      Delayed Upgrade Clock